Most adaptogen brands use doses so low they can't possibly work — proven by the clinical research. Here's what the studies actually require, what most products actually contain, and why it matters.
If you've bought an ashwagandha supplement and not noticed much difference. If you've tried a lion's mane product and still felt foggy. If you've been through multiple adaptogen blends without a clear result — you're not imagining it. You're not unusually resistant to these compounds. The products almost certainly didn't contain enough of the active ingredient to produce any measurable physiological effect.
This is the central, open secret of the UK adaptogen industry: the vast majority of products on the market are dosed so far below what clinical research uses that they cannot work. Not "might not work." Cannot. The pharmacology is clear. The dose-response is real. And the gap between what studies use and what products contain is enormous.
Here's the evidence.
Every adaptogen benefit you've read about — reduced cortisol, improved focus, better sleep, stress resilience — comes from peer-reviewed studies. Those studies use specific doses of specific extracts. Not "some ashwagandha." Specific, standardised extracts at specific milligram amounts, taken daily for specific durations.
The landmark studies on ashwagandha use KSM-66 — a full-spectrum root extract standardised to minimum 5% withanolides. The doses in studies showing measurable results:
Now look at a typical UK ashwagandha supplement. Many contain 100–200mg of generic ashwagandha root powder — not KSM-66, not standardised to any withanolide content. That's not 50% of the research dose. That's a fraction of the research dose delivered in a form that doesn't match what was studied. The chances of replicating those clinical outcomes are essentially zero.
The clinical trials showing cognitive benefits from lion's mane use:
Walk through any health food shop or UK supplement website. You'll find lion's mane products containing 50mg, 80mg, sometimes 100mg — of mycelium, not fruiting body, often extracted with water only, missing the hericenones entirely. A product with 50mg of mycelium-on-grain powder is not delivering 10% of the clinical dose. It's delivering something closer to 1–2% of a meaningful amount of actual active compounds. You will feel nothing. This is not a failure of adaptogens. It's a failure of product formulation.
Studies showing reductions in mental fatigue, burnout, and cognitive performance under stress use:
Generic "rhodiola extract" without stated standardisation tells you nothing. Rhodiola products standardised to rosavins only (without salidroside) are not using the natural compound ratio. Doses under 200mg are below the range of any positive human trial. Many UK products contain exactly these problems.
Meaningful reishi studies use 1–5g per day of standardised extract, dual-extracted to capture both water-soluble polysaccharides and alcohol-soluble triterpenes. The majority of "reishi capsules" in the UK contain 200–500mg of mycelium powder. That's neither the right part of the mushroom, nor the right extraction, nor the right dose.
This isn't an accident. It's a rational economic decision made by brands optimising for margin rather than efficacy.
KSM-66 ashwagandha at 600mg per serving costs significantly more per unit than generic ashwagandha root powder at 200mg. Dual-extracted lion's mane fruiting body at 1g per serving costs more than mycelium-on-grain powder at 50mg. When your business model is to sell supplements at a price point that competes with Amazon's cheapest options, ingredient quality and dose are the first things to cut.
The result is an industry where:
This is why "do adaptogens work?" is even a question. They work — when dosed properly. The studies are unambiguous. The problem is almost entirely in the products, not the ingredients.
Use this as a quick checklist:
Does the label say "KSM-66 ashwagandha" or "Sensoril" — or just "ashwagandha extract" or "ashwagandha root powder"? The named patented extract has a specific production process, standardised withanolide content, and the clinical trial evidence. A generic label does not.
Compare what's on the label to the doses in human studies:
A "proprietary adaptogen blend 500mg" containing lion's mane, ashwagandha, rhodiola, reishi, and bacopa means each ingredient has roughly 100mg or less — below clinical threshold for every single one. Proprietary blends exist to hide individual doses. If a brand won't tell you how much of each ingredient you're getting, assume it's not enough.
"Lion's mane extract" means nothing without knowing: fruiting body or mycelium? Water-extracted only, or dual-extracted (water + alcohol)? Beta-glucan content stated? A hot-water-only extract of lion's mane mycelium does not contain meaningful hericenones. You need dual-extracted fruiting body to get both the beta-glucans and the hericenones that the research attributes benefits to.
A common response to this is: "but quality supplements are expensive." Here's the reframe. An underdosed product at £20/month that produces no effect is infinitely more expensive than an effective product at £40/month that delivers what's advertised. You're not comparing £20 to £40. You're comparing £0 of value to £40 of value. Paying for something that doesn't work is not saving money.
There's also a direct cost comparison. To get 600mg of KSM-66 ashwagandha equivalent from a product containing 200mg of generic ashwagandha root powder, you'd need to take three servings — tripling your cost. A properly dosed product at a higher price point can easily be better value per effective dose. Run the maths on your current supplements.
A supplement you can actually expect to feel benefits from will have:
These products cost more to make. They will cost more to buy. That relationship is not a coincidence.
Adaptogens work. The clinical evidence is strong, consistent, and growing. But "adaptogens work" refers to specific compounds at specific doses — not to any product that includes the word "ashwagandha" on the label. Most UK supplement products are dosed so far below clinical thresholds that they are pharmacologically inert. If you've tried adaptogens and felt nothing, the overwhelming probability is that the product was the problem, not you. The solution is to find a product that actually doses to the science — and to demand that transparency before you buy. See our dosing-specific guides for each ingredient: ashwagandha, lion's mane, rhodiola, and reishi.
Featured In
NECTA FOCUS
The formula built around the ingredients covered in this article — clinically dosed, organic, UK made.
View NECTA FOCUS →The most likely reason is that the product you took was underdosed — containing far less of the active ingredient than the clinical studies that demonstrated benefits. Most UK adaptogen supplements contain 50–200mg of generic herb powder, when clinical trials showing measurable effects use 300–600mg of named standardised extracts like KSM-66 ashwagandha. A product with the right ingredient name but the wrong dose cannot produce the effects that ingredient is known for.
Clinical trials showing measurable cortisol reduction and stress resilience improvements use 300–600mg of KSM-66 or Sensoril ashwagandha — specific standardised extracts, not generic ashwagandha root powder. The landmark 2012 study by Chandrasekhar et al. found a 27.9% reduction in cortisol using 300mg KSM-66 twice daily. Below 300mg of a named standardised extract, results are unreliable and often absent.
The clinical trial showing significant cognitive improvements in humans (Mori et al., 2009) used 3g per day of dried lion's mane fruiting body over 16 weeks. Supplement studies use a minimum of 500mg of dual-extracted fruiting body extract. Most UK lion's mane products contain 50–200mg of mycelium-on-grain powder — neither the right part of the mushroom, nor the right extraction, nor the right dose. You need dual-extracted fruiting body extract at 500mg minimum.
A proprietary blend lists multiple ingredients under a single combined weight — for example, "adaptogen complex 500mg" containing ashwagandha, lion's mane, rhodiola, and reishi. The individual amounts are hidden. In practice, this almost always means each ingredient is present at sub-clinical doses — often 50–100mg each. Proprietary blends exist to obscure how little of each ingredient is actually in the product. Always buy supplements that list every ingredient's individual dose.
Almost never. The cost of quality adaptogenic ingredients at clinical doses is significant — KSM-66 ashwagandha at 600mg per serving, dual-extracted lion's mane fruiting body at 1g per serving, and standardised rhodiola all cost meaningfully more than generic herb powders. A cheap adaptogen supplement is almost always cheap because it contains underdosed, low-quality ingredients. Paying £20/month for something that produces no effect is more expensive than paying £40/month for something that actually works.
Best Adaptogens for Stress and Anxiety in 2026
From ashwagandha to rhodiola, we rank the best adaptogens for stress relief and anxiety based on clinical evidence — and explain how to actually use them.
How to Lower Cortisol Naturally: 7 Evidence-Backed Methods
High cortisol is linked to anxiety, weight gain, poor sleep, and brain fog. Here are 7 science-backed ways to bring it down — including the adaptogens with the strongest evidence.
Brain Fog Supplements: What Actually Works, According to the Evidence
Brain fog — that feeling of slow, cloudy thinking — affects millions of UK adults. Here are the supplements with real clinical evidence behind them, and the lifestyle factors that matter more.